2025-11-16 - Analysis Report
Okay, here's an analysis of Albemarle Corp (ALB) based on the data you provided, presented in an organized report format:

## Albemarle Corp (ALB) Stock Analysis

**Company Overview:** Albemarle Corp is a specialty chemicals company with leading positions in lithium, bromine, and catalysts.

### 1. Performance vs. S&P 500 (VOO)

*   **Cumulative Return (ALB):** 11.11%
*   **Cumulative Return (VOO):** 98.45%
*   **Absolute Divergence:** -110.6
*   **Relative Divergence:** 3.2

**Analysis:**  ALB has significantly underperformed the S&P 500 (VOO) over the period covered by the cumulative return data. The absolute divergence shows a large gap in returns.  The relative divergence indicates that ALB's underperformance is near the lower end of its historical range relative to the S&P 500.

**Historical Performance Analysis:**

| Year       | CAGR      | MDD      | Alpha    | Beta   | Cap(B) |
|------------|-----------|----------|----------|--------|--------|
| 2015-2017  | 85.0%     | 68.0%    | 57.0%    | 0.0    | 15.1   |
| 2016-2018  | 9.0%      | 68.0%    | -6.0%    | 0.0    | 9.1    |
| 2017-2019  | -44.0%    | 73.9%    | -66.0%   | 0.1    | 8.6    |
| 2018-2020  | 44.0%     | 79.4%    | 20.0%    | 0.2    | 17.4   |
| 2019-2021  | 149.0%    | 79.4%    | 103.0%   | -0.1   | 27.5   |
| 2020-2022  | 148.0%    | 79.9%    | 149.0%   | 0.5    | 25.5   |
| 2021-2023  | -26.0%    | 81.9%    | -27.0%   | 0.5    | 17.0   |
| 2022-2024  | -152.0%   | 81.9%    | -172.0%  | 0.3    | 10.1   |
| 2023-2025  | -210.0%   | 81.9%    | -273.0%  | -1.0   | 13.6   |

**Analysis:**

*   **CAGR:** The Compound Annual Growth Rate varies significantly across different periods, showing high volatility.  The recent periods (2022-2025) exhibit substantial negative growth.
*   **MDD:** The Maximum Drawdown is consistently high, indicating significant risk of loss.
*   **Alpha:**  Alpha, which measures performance above the benchmark, is largely negative in recent periods, confirming underperformance.
*   **Beta:** Beta values are relatively low, suggesting the stock is less sensitive to market movements. The negative beta in 2019-2021 indicates an inverse correlation during that period.
*   **Market Cap:** Market Cap has fluctuated and decreased significantly in recent years.

### 2. Recent Price Action

*   **Current Price:** 115.14
*   **Previous Close:** 114.57
*   **Change:** 0.5
*   **5-day Moving Average:** 109.498
*   **20-day Moving Average:** 99.0725
*   **60-day Moving Average:** 89.5013

**Analysis:** The stock price is above its 5, 20, and 60-day moving averages, indicating a short-term upward trend.  The recent small price increase suggests a continuation of this upward momentum, especially given the larger jump from the previous close.

### 3. Technical Indicators and Outlook

*   **Market Risk Indicator (MRI):** 0.8 (Medium Investment)
*   **RSI:** 73.71 (Overbought)
*   **PPO:** 1.6874
*   **Hybrid Signal:**  Cash_0%_Buy 100% (9 shares - Very Safe - MRI:0.90)
*   **Recent (20-day) Relative Divergence Change:** -1.0 (Short-term decrease)
*   **Expected Return:** 889.2% (Long-term, vs. S&P 500)

**Analysis:**

*   **MRI:** A medium investment recommendation suggests moderate risk.
*   **RSI:** The RSI is in overbought territory, suggesting the stock may be due for a pullback or consolidation.
*   **PPO:** The Positive Percentage Oscillator (PPO) indicates the price is trending above its moving average.
*   **Hybrid Signal:** The hybrid signal recommends buying, but the MRI used within the signal suggests caution.
*   **Relative Divergence:** The recent decrease in relative divergence supports the potential for a short-term price correction.
*   **Expected Return:** The extremely high expected return suggests significant long-term potential relative to the S&P 500, but should be viewed with caution due to the inherent uncertainty of long-term forecasts.

### 4. Recent News & Significant Events

*   **Price Target Upgrade:** Insider Monkey reported ALB rallying on a price target upgrade.
*   **Weekly Rally:** Motley Fool analyzed the factors behind Albemarle's 18% weekly surge.
*   **Analyst Adjustments:** UBS adjusted its price target on Albemarle to $107 from $85, maintaining a neutral rating.
*   **Lithium Supply Deals:** Simply Wall St. examined whether Albemarle's lithium supply deals signal real value after a 17% weekly rally.

**Analysis:** Recent news is generally positive, focusing on a rally, price target upgrades, and analysis of lithium supply deals.  However, the UBS analyst maintaining a neutral rating, even with a price target increase, suggests some remaining caution.

### 4-2. Analyst Opinions

*   **Consensus:** Hold (2.65)
*   **Opinions:** 23
*   **Target Price:** 102.53 (avg) / 200.00 (high) / 58.00 (low)

**Analysis:** The analyst consensus is a "Hold" with a wide range of target prices, indicating uncertainty about the stock's future performance.  The average target price is below the current price, suggesting analysts, on average, believe the stock is currently overvalued.

### 5. Recent Earnings Analysis

| Date       | EPS   | Revenue     |
|------------|-------|-------------|
| 2025-11-05 | -1.72 | 1.31 B$     |
| 2025-08-04 | -0.16 | 1.33 B$     |
| 2025-04-30 | 0     | 1.08 B$     |
| 2024-11-06 | -9.45 | 1.35 B$     |
| 2025-11-05 | -9.45 | 1.35 B$     |

**Analysis:** Earnings per share (EPS) has been negative in recent quarters, indicating unprofitability. While revenue has been relatively stable, the significant EPS losses raise concerns.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
|--------------|------------|---------------|
| 2025-09-30   | $1.31B     | 8.99%         |
| 2025-06-30   | $1.33B     | 14.80%        |
| 2025-03-31   | $1.08B     | 14.51%        |
| 2024-12-31   | $1.23B     | 11.22%        |
| 2024-09-30   | $1.35B     | -7.68%        |

**Capital and Profitability:**

| Quarter      | Equity     | ROE       |
|--------------|------------|-----------|
| 2025-09-30   | $10.00B    | -1.61%    |
| 2025-06-30   | $10.24B    | 0.22%     |
| 2025-03-31   | $10.03B    | 0.41%     |
| 2024-12-31   | $9.96B     | 0.76%     |
| 2024-09-30   | $10.24B    | -10.44%   |

**Analysis:**

*   **Revenue & Profitability:** While revenue has been relatively consistent, profit margins have fluctuated, with a notable negative margin in Q3 2024. More recent quarters show positive, but varying, profitability.
*   **Capital & Profitability:** Equity has remained relatively stable.  Return on Equity (ROE) has been weak, with negative values in two of the last five quarters, reflecting the recent unprofitability.

### 7. Summary and Conclusion

Albemarle Corp (ALB) is currently exhibiting mixed signals. While the stock has seen a recent upward trend and positive news catalysts, there are several concerning factors:

*   **Significant Underperformance:** ALB has significantly underperformed the S&P 500.
*   **Negative Earnings:**  Recent EPS figures are negative, indicating unprofitability.
*   **Weak ROE:** Return on Equity is also weak, reflecting the recent unprofitability.
*   **Analyst Uncertainty:**  Analyst consensus is a "Hold" with a wide range of target prices.
*   **Overbought RSI:** The RSI indicates the stock may be overbought in the short term.

**Overall:**  ALB's recent rally and positive news should be viewed cautiously. The company's fundamental performance (earnings, ROE) raises concerns.  While the long-term expected return is high, the near to medium-term outlook appears uncertain. Investors should carefully weigh the potential risks and rewards before making any investment decisions. A potential short-term pullback should be expected.
